SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
AURELIUS Equity Opportunities SE & Co. KGaA (AULRF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 58/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AULRF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.04
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.33
Book Value / Share$0.00
Revenue / Share$108.75
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$0.10 |
$1.46B |
$2.15M |
0.1% |
| 2014 |
$3.07 |
$1.53B |
$104.04M |
6.8% |
| 2015 |
$4.91 |
$2.01B |
$155.87M |
7.7% |
| 2016 |
$0.22 |
$2.57B |
$7.43M |
0.3% |
| 2017 |
$14.72 |
$3.35B |
$483.8M |
14.4% |
| 2018 |
$-1.60 |
$3.39B |
$-50.71M |
-1.5% |
| 2019 |
$0.57 |
$3.19B |
$18.4M |
0.6% |
| 2020 |
$3.37 |
$3.15B |
$104.8M |
3.3% |
| 2021 |
$4.86 |
$2.56B |
$139.3M |
5.4% |
| 2022 |
$-1.33 |
$3B |
$82.3M |
2.7% |
